Analysts at StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of Bellerophon Therapeutics stock opened at $0.04 on Friday. The firm has a market cap of $440,388.00, a PE ratio of -0.04 and a beta of 0.70. The stock has a 50 day moving average of $0.04 and a 200 day moving average of $0.05. Bellerophon Therapeutics has a 12 month low of $0.03 and a 12 month high of $0.42.
Bellerophon Therapeutics Company Profile
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- 3 Fintech Stocks With Good 2021 Prospects
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is MarketRank™? How to Use it
- MarketBeat Week in Review – 9/23 – 9/27
- How to Capture the Benefits of Dividend Increases
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.